NVS - Novartis AG - ADR
Close
120.89
0.470 0.389%
Share volume: 902,626
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$120.42
0.47
0.39%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-10-25 | 2023-02-01 | 2023-04-25 | 2023-07-18 | 2023-10-24 | 2024-01-31 | 2024-04-23 | 2024-07-18 | |
Total revenue | 12.842 B | 13.087 B | 13.208 B | 13.936 B | 12.092 B | 7.424 B | 12.120 B | 12.872 B | |
Cost of revenue | 3.806 B | 4.073 B | 3.931 B | 4.341 B | 3.117 B | 1.083 B | 3.096 B | 3.173 B | |
Gross profit | 9.036 B | 9.014 B | 9.277 B | 9.595 B | 8.975 B | 6.341 B | 9.024 B | 9.699 B | |
-0.24% | 2.92% | 3.43% | -6.46% | -29.35% | 42.31% | 7.48% | |||
Operating expenses | 6.149 B | 6.189 B | 6.237 B | 6.212 B | 7.016 B | 4.423 B | 5.261 B | 5.458 B | |
Selling general and admin | 3.413 B | 3.747 B | 3.443 B | 3.686 B | 3.091 B | 2.297 B | 2.840 B | 3.091 B | |
Research and development | 2.736 B | 2.442 B | 2.794 B | 2.526 B | 3.925 B | 2.126 B | 2.421 B | 2.367 B | |
Total expenses | 9.959 B | 10.256 B | 10.169 B | 10.555 B | 10.557 B | 5.092 B | 9.025 B | 9.133 B | |
2.98% | -0.85% | 3.80% | 0.02% | -51.77% | 77.24% | 1.20% | |||
Operating income | 2.883 B | 2.831 B | 3.039 B | 3.381 B | 1.535 B | 2.332 B | 3.095 B | 3.739 B | |
Ebit | 2.883 B | 2.822 B | 3.039 B | 3.381 B | 1.759 B | 2.108 B | 3.344 B | 4.012 B | |
Pretax income | 1.919 B | 1.741 B | 2.740 B | 2.769 B | 1.552 B | 2.062 B | 3.129 B | 3.841 B | |
-9.28% | 57.38% | 1.06% | -43.95% | 32.86% | 51.75% | 22.75% | |||
Income tax | 344.000 M | 275.000 M | 446.000 M | 452.000 M | 39.000 M | -386.000 M | 441.000 M | 595.000 M | |
Net income basic | 1.573 B | 1.466 B | 2.293 B | 2.316 B | 1.761 B | 8.480 B | 2.688 B | 3.246 B | |
-6.80% | 56.41% | 1.00% | -23.96% | 381.54% | -68.30% | 20.76% | |||
Net income | 1.573 B | 1.466 B | 2.293 B | 2.316 B | 1.761 B | 8.480 B | 2.688 B | 3.246 B | |
-6.80% | 56.41% | 1.00% | -23.96% | 381.54% | -68.30% | 20.76% |